Clinical Education InitiativeMenu
Search
Home > Courses > HIV to HIV Transplantation: Hope in Action

HIV to HIV Transplantation: Hope in Action

HIV to HIV Transplantation: Hope in Action
Play
Sorry, this learning module is not available for mobile devices.
Original Presentation: 6/14/2016
Web Posting: 10/28/2016
CE Expiration: 06/13/2019
Presenter
  • Christine M. Durand, MD
    Assistant Professor
    Johns Hokins School of Medicine
Learning Objectives
At the completion of this educational session, participants will:
  1. Know the guidelines to select appropriate HIV-positive candidates for organ transplantation.
  2. Understand the management challenges for HIV-positive transplant recipients.
  3. Be aware of the recent changes in federal law allowing for the use of HIV-positive donors.
  4. Appreciate the knowledge gaps and risks of using HIV-positive donors.
Presenter Bio
Christine Durand, MD
Dr. Christine Durand leads the evaluation and management of all HIV-infected solid organ and bone marrow transplant candidates at Johns Hopkins. Her current research includes both epidemiologic, translational and clinical studies focused on HIV and HCV infected transplant recipients. In addition, she has a particular interest in the impact of cancer and transplant therapies on HIV cure.
Continuing Education Credit

This CME activity was approved for AMA PRA Category 1 Credit™ on June 14, 2016 and will terminate June 13, 2019.

The target audience is all physicians, NPs and PAs involved or interested in HIV education.

This online video and post-activity evaluation are one hour in length.

  • After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
  • You must achieve at least 70% correct to receive your CME certificate.
  • If successful, you will be provided instructions to print your CME certificate at the completion of this activity.

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.

The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit. Physicians should claim only the credit commensurate with extent of their participation in the activity.

Disclosure Statement 

Policies and standards of MSSNY require that speakers and planners for CME activities disclose any relevant financial relationships they may have with commercial interests whose products, devices or services may be discussed in the content of a CME activity. 

  • Dr. James Braun (Planner/Course Director) had no relevant financial relationships to disclose.
  • Dr. Christine Durand (Presenter) had the following personal financial relationships in prior 12 months with manufacturers of the products or services that may be presented in the CME activity:  Advisory boards of  Gilead, BMS, and Merck; research grants from Gilead, and BMS; review panel member with Gilead. Dr. Durand submitted her presentation and clinical recommendations with the best available evidence from the medical literature.

Financial Support

This meeting of the Physicians' Research Network (PRN) and enduring material were funded in part by educational grants from: Bristol-Myers Squibb, Gilead Sciences, Janssen Pharmaceuticals, Merck & Co, and ViiV Healthcare.

Details:

  • This online video and post-activity evaluation are one hour in length. 
  • After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz. 
  • You must achieve at least 70% correct to receive your CME certificate. 
  • If successful, you will be provided instructions to print your CME certificate at the completion of this activity.
PRN Learning Modules